假定不良结果路径帕金森病类似症状诱导量子点基于体内/体外方法
Min Chen1,2, Siyuan Chen1, Kehan Liu1
1Key Laboratory of Environmental Medicine and Engineering, Ministry of Education; School of Public Health, Southeast University, Nanjing 210009, P. R. China.
ACS nano
|August 26, 2024
概括
量子点 (SiQD) 在神经元中积累,通过诱导铁亡,引起帕金森病类症状. 这项研究强调了SiQDs的神经退行性风险,为公共卫生政策提供了信息.
科学领域:
- 纳米技术纳米技术
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
背景情况:
- 量子点 (SiQD) 越来越普遍,引发了对环境分散和健康影响的担忧.
- 帕金森病 (PD) 是一种具有复杂病因的渐进性神经退行性疾病.
研究的目的:
- 调查SiQDs对帕金森病类症状发展的毒理学影响.
- 阐明SiQD诱导的神经退行症的潜在机制,重点关注铁亡.
主要方法:
- 使用了体内 (Caenorhabditis elegans) 和体外 (SH-SY5Y神经母细胞瘤细胞) 模型.
- 描述了SiQDs的物理化学特性及其在神经组织中的积累.
- 评估了多巴胺基神经退行,多巴胺依赖性行为和PD特异性基因表达.
- 研究了铁素和铁死在SiQD毒性的作用.
主要成果:
- SiQDs在神经元组织中积累,导致多巴胺基神经退行症和降低多巴胺依赖行为的C. 伊莱根斯 (elegans) 是一个词.
- SiQDs触发了ferritinophagy,一种诱导ferroptosis并导致PD类症状的途径.
- 在生物模型中,SiQD暴露加剧了疾病的进展.
结论:
- SiQDs通过铁亡途构成显著的神经退行性风险.
- 这些发现支持开发SiQDs的不良结果路径框架.
- 强调需要制定关于SiQD监管的政策,以保护公众健康并指导负责任的纳米技术发展.
相关概念视频
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


